In Massachusetts and Iowa, DuPont Pioneer and the Broad Institute of MIT and Harvard reached an agreement to jointly provide non-exclusive licenses to foundational CRISPR-Cas9 intellectual property under their respective control for use in commercial agricultural research and product development.
These two major CRISPR-Cas9 license holders are coming together with the shared goal of enabling all entities wanting to apply the technology for agricultural applications with a full range of CRISPR-Cas9 tools. Broad access to foundational intellectual property for CRISPR-Cas9 technology will be freely available to universities and nonprofit organizations for academic research.
“When DuPont Pioneer initially approached us to secure a license for commercial research, we both saw a unique opportunity to provide much broader access to the technology for agriculture,” said Eric Lander, president and founding director of the Broad Institute. “We applaud DuPont Pioneer for its commitment to advancing research and commercialization to accelerate progress in agriculture.”